Placebo bupropion

DRUG5 trials

Sponsors

University of Pennsylvania, National Institute on Drug Abuse (NIDA), Duke University, Shanghai Mental Health Center, Rose Research Center, LLC

Conditions

Cigarette-smokingNicotine DependenceObeseSchizophreniaSleep DisordersSmoking CessationTobacco Use CessationTobacco Use Disorder

Phase 2

Comparing Smoking Treatment Programs for Lighter Smokers - 1

CompletedNCT00086411

University of PennsylvaniaTobacco Use Disorder

Start: 2003-09-30End: 2009-06-30Updated: 2019-08-06

Phase 3

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation

CompletedNCT01406223

Duke UniversityNicotine Dependence

Start: 2011-07-31End: 2014-06-30Updated: 2017-11-14

The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette

CompletedNCT05205811

Rose Research Center, LLCSmoking Cessation

Start: 2021-12-14End: 2025-10-13Updated: 2026-02-06

Phase 4

Impact of Smoking Cessation on Sleep - 5

CompletedNCT00132821

National Institute on Drug Abuse (NIDA)Sleep Disorders, Tobacco Use Cessation

Start: 2005-08-31End: 2009-05-31Updated: 2017-01-12

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

CompletedNCT02736474

Shanghai Mental Health CenterCigarette-smoking, Obese, Schizophrenia

Start: 2016-05-31End: 2018-07-31Updated: 2021-10-22

Related Papers

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia

Frontiers in Pharmacology2018-03-0526 citations